Natural combination hormone replacement formulations and therapies
DCFirst Claim
Patent Images
1. A pharmaceutical composition comprising:
- solubilized estradiol;
suspended progesterone;
and a solubilizing agent;
wherein each of the estradiol and the suspended progesterone are present in the solubilizing agent and the estradiol and progesterone are uniformly dispersed;
wherein at least about 90% of the estradiol is solubilized in the solubilizing agent; and
wherein the solubilizing agent comprises an effective amount of at least one of mono-, di-, and triglycerides containing an ester of a C6-C12 fatty acid.
9 Assignments
Litigations
0 Petitions
Accused Products
Abstract
Estrogen and progesterone replacement therapies are provided herein. Among others, the following formulations are provided herein: solubilized estradiol without progesterone; micronized progesterone without estradiol; micronized progesterone with partially solubilized progesterone; solubilized estradiol with micronized progesterone; solubilized estradiol with micronized progesterone in combination with partially solubilized progesterone; and solubilized estradiol with solubilized progesterone.
-
Citations
15 Claims
-
1. A pharmaceutical composition comprising:
-
solubilized estradiol; suspended progesterone; and a solubilizing agent; wherein each of the estradiol and the suspended progesterone are present in the solubilizing agent and the estradiol and progesterone are uniformly dispersed; wherein at least about 90% of the estradiol is solubilized in the solubilizing agent; and wherein the solubilizing agent comprises an effective amount of at least one of mono-, di-, and triglycerides containing an ester of a C6-C12 fatty acid. - View Dependent Claims (2, 3, 4, 5)
-
-
6. A pharmaceutical composition comprising:
-
solubilized estradiol; suspended progesterone; and a solubilizing agent, the solubilizing agent comprising an effective amount of mono-, di-, and triglycerides containing an ester of a C6-C12 fatty acid; wherein the estradiol and the suspended progesterone are present in the solubilizing agent the estradiol and progesterone are uniformly dispersed, and at least about 90% of the estradiol is solubilized in the solubilizing agent; and wherein the estradiol does not precipitate for at least 14 days. - View Dependent Claims (7, 8, 9, 10)
-
-
11. A method of treating menopause symptoms of a woman with a uterus comprising:
-
administering an effective amount of a pharmaceutical composition, the pharmaceutical composition comprising solubilized estradiol, suspended progesterone, and a solubilizing agent, wherein each of the estradiol and the suspended progesterone are present in the solubilizing agent and the estradiol and the suspended progesterone are uniformly dispersed and at least about 90% of the estradiol is solubilized in the solubilizing agent; and wherein the solubilizing agent comprises an effective amount of at least one of mono-, di-, and triglycerides containing an ester of a C6-C12 fatty acid. - View Dependent Claims (12, 13, 14, 15)
-
Specification